A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis

Cancer Prevention Research

Volumn 7, Issue 7, 2014, Pages 666-674

  Wang, Li Shu ^a   Burke, Carol A ^b   Hasson, Henrietta ^b   Kuo, Chieh Ti ^a   Molmenti, Christine L Sardo ^e   Seguin, Claire ^c   Liu, Pengyuan ^a   Huang, Tim H M ^f   Frankel, Wendy L ^d   Stoner, Gary D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLACK RASPBERRY EXTRACT; DNA; DNA METHYLTRANSFERASE 1; GLUCOSE; MALTODEXTRIN; MEMBRANE PROTEIN; PLACEBO; PLANT EXTRACT; PROTEIN P16; SECRETED FRIZZLED RELATED PROTEIN 2; UNCLASSIFIED DRUG; WIF1 PROTEIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; BLACK RASPBERRY; BLACKBERRY; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRUG EFFICACY; FAMILIAL COLON POLYPOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RASPBERRY; RECTUM; RECTUM ADENOMA; RECTUM POLYP; SUPPOSITORY; TRANSCRIPTION INITIATION SITE; TREATMENT DURATION; TUMOR VOLUME; WNT SIGNALING PATHWAY; ADENOMA; ADENOMATOUS POLYPOSIS COLI; CASE CONTROL STUDY; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; FOLLOW UP; FRUIT; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; POLYP; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RUBUS;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; CASE-CONTROL STUDIES; CELL PROLIFERATION; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; FRUIT; HUMANS; MALE; MIDDLE AGED; POLYPS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECTUM; RUBUS;

EID: 84904320624     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0052     Document Type: Article

References (28)

1. Church J, Burke C, McGannon E, Pastean O, Clark B. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 2003;46:1175-81. (Pubitemid 37129554)
2. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-7. (Pubitemid 13004158)
3. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002;122:641-5. (Pubitemid 34173815)
4. Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z, et al. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum 2001;44:1090-7.
5. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-9.
6. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6. (Pubitemid 23131373)
7. Steinbach G, Lynch PM, Phillips RKS, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52. (Pubitemid 30419089)
8. Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003;9:4756-60. (Pubitemid 37323278)
9. Couzin J. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 2004;306:384-5. (Pubitemid 39372409)
10. Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006;4:1035-8. (Pubitemid 44118839)
11. Stoner GD. Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev Res 2009;2:187-94.
12. -/- mouse models of colorectal cancer. Cancer Prev Res 2010;3:1443-50.
13. Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, Frankel WL, et al. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer 2001;40:125-33. (Pubitemid 34274918)
14. Wang LS, Arnold M, Huang YW, Sardo C, Seguin C, Martin E, et al. Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 2011;17:598-610.
15. Kresty LA, Frankel WL, Hammond CD, Baird ME, Mele JM, Stoner GD, et al. Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr Cancer 2006;54:148-56. (Pubitemid 44141344)
16. Shumway BS, Kresty LA, Larsen PE, Zwick JC, Lu B, Fields HW, et al. Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin Cancer Res 2008;14:2421-30. (Pubitemid 351551076)
17. Mallery SR, Zwick JC, Pei P, Tong M, Larsen PE, Shumway BS, et al. Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res 2008;68:4945-57.
18. Denis H, Ndlovu MN, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 2011;12:647-56.
19. Schmidt WM, Sedivy R, Forstner B, Steger GG, Zöchbauer-Müller S, Mader RM. Progressive upregulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 2007;46:766-72. (Pubitemid 47438727)
20. Wynter CVA, Kambara T, Walsh MD, Leggett BA, Young J, Jass JR. DNA methylation patterns in adenomas from FAP, multiple adenoma, and sporadic colorectal carcinoma patients. Int J Cancer 2006;118:907-15. (Pubitemid 43158453)
21. Berkhout M, Nagtegaal ID, Cornelissen SJB, Dekkers MMG, van de Molengraft FJJM, Peters WHM, et al. Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. Mod Pathol 2007;20:1253-62. (Pubitemid 350126848)
22. Wang LS, Hecht SS, Carmella SG, Yu N, Larue B, Henry C, et al. Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res 2009;2:84-93.
23. Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, et al. Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res 2011;71:1752-62.
24. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009;41:178-86.
25. Chen T, Yan F, Qian J, Guo M, Zhang H, Tang X, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res 2012;5:41-50.
26. Nugent KP, Phillips RK, Hodgson SV, Cottrell S, Smith-Ravin J, Pack K, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 1994;35:1622-3. (Pubitemid 24339265)
27. Debinski HS, Love S, Spigelman AD, Phillips RK. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996;110:1028-30. (Pubitemid 26113740)
28. Issa JP.DNA methylation as a therapeutic target in cancer. Clin Cancer Res. 2007;13:1634-7.